Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,596,685
-$316,118 QoQ
Shares Held
65,349
-5.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.16%
of 13F equity value
Holder Rank
#834
of 4,676 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 3%
Shared 25%
None 72%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Regal Investment Advisors LLC holds $56,143,765 across 10 Drug Manufacturers - General names. JNJ ranks #2 (29.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
69,318 | $17,443,181 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
65,349 | $16,596,685 | |
| 3 | PFE |
Pfizer Inc
|
378,806 | $9,121,648 | |
| 4 | LLY |
ELI LILLY & Co
|
4,324 | $5,186,335 | |
| 5 | MRK |
Merck & Co., Inc.
|
26,367 | $3,388,159 | |
| 6 | AMGN |
Amgen Inc
|
4,280 | $1,549,873 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,352 | $942,202 | |
| 8 | NVS |
Novartis AG
|
5,361 | $840,175 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,596,685 | 65,349 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,912,803 | 69,190 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,851,973 | 71,766 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,326,135 | 71,870 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,852,582 | 71,048 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $11,591,386 | 69,895 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $13,149,284 | 90,923 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,817,307 | 91,431 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $12,766,929 | 87,349 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $13,461,969 | 85,100 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,398,448 | 85,482 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,391,852 | 85,983 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $13,838,465 | 83,606 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $12,516,715 | 80,753 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $13,362,865 | 75,646 | Shares | Sole | 2023-03-01 | |
| 2022-09-30 | $11,776,295 | 72,088 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $12,035,888 | 67,804 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $11,408,117 | 64,369 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $10,460,246 | 61,146 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,744,910 | 60,340 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $9,268,601 | 56,262 | Shares | Sole | 2021-08-09 | |
| 2020-12-31 | $10,151,167 | 64,501 | Shares | Sole | 2021-02-12 | |
| 2020-06-30 | $8,804,422 | 62,607 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||